Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Garcin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal Francais D'Ophtalmologie|February 13, 2022
Who first described Descemetorhexis without endothelial keratoplasty (DWEK) for the management of Fuchs' corneal endothelial dystrophy?G Thuret, S Poinard, T Garcin, et al.
The Review of Scientific Instruments|November 10, 2009
High temperature dilatation measurements by in situ laser interferometry under high magnetic fieldS Rivoirard, T Garcin, E Beaugnon, et al.
Journal Francais D'Ophtalmologie|February 22, 2021
[Corneal perforation with tyrosine kinase inhibitor chemotherapy: REGORAFENIB]L Lanfant, M C Trone, T Garcin, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal Francais D'Ophtalmologie|February 13, 2022
Who first described Descemetorhexis without endothelial keratoplasty (DWEK) for the management of Fuchs' corneal endothelial dystrophy?G Thuret, S Poinard, T Garcin, et al.
The Review of Scientific Instruments|November 10, 2009
High temperature dilatation measurements by in situ laser interferometry under high magnetic fieldS Rivoirard, T Garcin, E Beaugnon, et al.
Journal Francais D'Ophtalmologie|February 22, 2021
[Corneal perforation with tyrosine kinase inhibitor chemotherapy: REGORAFENIB]L Lanfant, M C Trone, T Garcin, et al.
Pageof 1